The remarkable success of medical imaging over the last forty years is almost wholly due to continuous important innovation. Both imaging providers and the makers of imaging technologies have prospered. The future advancement of radiology requires the same level of innovation. However, this innovation cannot occur in isolation. Successful new imaging technologies must conform to the new paradigm of personalized medicine, also known as 'P4 medicine.' Radiologists' participation in P4 medicine requires that future novel imaging technologies must provide care that addresses one or more of four qualities. They must be:
• Predictive of patient risks to improve and make more efficient disease surveillance; • Preemptive, so disease is found earlier when it is treatable with less morbidity and mortality; • Personalized, based on the individual's genome and life experiences; • Participatory, allowing patient preferences to help determine the most appropriate care. A plethora of such technologies are in the pipeline but major adverse environmental influences are affecting their progress towards implementation in clinical care. These include: a bias on the part of nonradiologist providers, regulators, and payers that imaging is being performed wastefully, leading to enhanced efforts to suppress imaging; the persistent economic effects of the recent recession; greater concerns than in the past over diagnostic radiation; and the absence of a clear cut financial model that will make personalized imaging sufficiently profitable for companies to develop new personalized imaging technologies. The last is particularly germane. As personalized medical products become more sophisticated, they will increasingly segment the population of patients for whom they can suitably be applied. Companies will find it difficult to rationalize the very expensive product development, testing, and approval cycle for a diminishing number of patients for whom the product is intended. For these reasons, successful imaging innovations will need to be able to cross four hurdles. First, they must prove that they provide a benefit to patients over and above that of existing technologies. By 'benefit,' it is meant that the new product must be safer, more effective, less invasive or painful, or in some way be perceived by patients and their doctors as an improvement in care. Second, the innovation must fit with little effort into the context of existing care. Third, the product must be a good value -the cost/benefit ratio will have to be as good or better than what is in current use. And finally, society must be able to afford to pay for it. These are difficult requirements to meet. Nonetheless, the transition to personalized medicine is inevitable. Radiologists must partner with vendors to ensure imaging a continuing role in future health care.
How has radiation epidemiology helped to protect patients? The past, present and future of radiation epidemiology (abridged) M Pearce
Institute of Health and Society, Newcastle University, United Kingdom
Epidemiology is crucial in determining risks related to radiation, and has provided the evidence base for radiation protection for many years. This talk will take a brief and selective historical review of radiation epidemiology, from the discovery of X-rays to the present day. Early evidence for adverse radiation effects came from medical settings with cancers noted in early radiologists and in thorotrast patients, but also in other occupational settings. The atomic bombings of Hiroshima and Nagasaki in August 1945 gave rise to the range of epidemiology studies that provide most of the evidence for our current evidence of radiation effects. However, this is not a field that stands still and the risk estimates continue to be updated with other studies and exposures in other settings and at lower doses. Such studies include those of radon, prenatal X-rays, employment in nuclear installations (and living nearby) and a range of studies related to the Chernobyl accident. This has resulted in a large increase in the understanding of radiation effects and reductions in exposures to the public and to workers, none of which is possible without the evidence provided from epidemiology. A greater understanding of risks at low doses is also crucial to protecting patients. This is the area in which much future research needs to concentrate, with many studies now focussing on patients exposed to relatively low levels of radiation through diagnostic and interventional radiology procedures.
1) Attention to Clinical History: While many MSK MR examinations
can be performed utilising standardised protocols, a significant number require tailored, customised examinations to assess the clinical problem. This frequently requires radiologist input at the protocol stage. 2) Use of Skin Markers: Placement of vitamin E capsule markers on the skin overlying an area of pain or swelling can be extremely helpful in identifying the symptomatic lesion in a patient, which otherwise may go undetected. 3) Coil Selection: An adequate array of surface coils for MSK imaging is required. In general, the main criterion in coil selection should be maximising spatial resolution. Sometimes spatial resolution may need to be sacrificed in order to gain adequate longitudinal coverage. 4) Use of Appropriate Imaging Planes: Double oblique sequence prescriptions are frequently required to optimally demonstrate anatomy and pathology in musculoskeletal imaging. Use of standard sagittal, axial and coronal imaging planes frequently results in suboptimal demonstration of anatomical structures. 5) Failure to Get to the Margins of the Pathology: Occasionally, despite appropriate protocol selection for the clinical history, an examination may not extend beyond the margins of a pathology. This most commonly occurs in the setting of an incidental mass lesion. A proactive approach by the MR radiographer in adding sequences and low threshold for getting the examination checked by a radiologist can help reduce the incidence of patient recalls.
6) Pitfalls in Interpretation:
In each anatomic region, there are a number of pathologies whose appearance on MRI may be misinterpreted as reflecting an alternative pathology. A number of these pathologies will be presented. 7) Trauma vs Tumour: Occasionally a tumour may present with a misleading history of trauma, tempting a diagnosis of traumatic haematoma. The reverse may also occur where it is difficult to differentiate a haematoma from a tumour. 1 Typically associated with early childhood and adolescence (<20 years), lesions are normally asymptomatic; however, pathological fracture occurs in more than 50% of cases and is frequently the first sign of disease presence. 2 In the absence of fracture, lesions often spontaneously resolve with skeletal maturity and are rarely found in adults.
3-4
On plain x-ray, simple bone cysts appear as well-defined medullary based lucencies with adjacent cortical thinning and a characteristically narrow transitional zone. 2 Treatment options for non-fractured cysts are varied, with management directed by age, epiphyseal plate involvement and fracture risk. 4 In this case, a conservative management strategy, focused on fracture healing was adopted as the associated fracture haematoma can promote cyst resolution.
Conclusion: Simple bone cysts are benign lytic lesions rarely found in skeletally mature adults. This case study presents an atypical 32-yearold patient with a complicating pathological fracture. Clinical and pathological manifestations of the patient's underlying disease are explored along with imaging characteristics and treatment implications. Aim: Historically, radiography training has focused mainly on the acquisition of technical skills. The importance of evidence-based practice (EBP) has recently led to awareness in the profession that research skills and knowledge of research concepts are fundamental components of training. However, few courses incorporate EBP or research into the curriculum. At Monash University, final year (4th year) radiography students undertake a core programme of EBP and research methodology over one semester. The aim of this study was to evaluate if students' perception and attitudes towards EBP and research improve after delivery of the programme. Methods: All final year radiography students were invited to participate in a survey that was conducted at the beginning and again at the end of the semester after delivery of a core unit on EBP and research methodology. The questions aimed to evaluate skill acquisition, such as research project design, communication, scientific writing, presentation skills and students' perception of research as a core tool for the radiography profession. Each question was scored on a scale from 1 to 7 (strongly agree -strongly disagree) and analysed using the Wilcoxon signed rank test.
Results: All survey questions had improved scores after delivery of the training module (12 were significantly improved, p < 0.05). Delivery of a unit on EBP significantly improved the knowledge and confidence of radiography students in their own research skills, as well as their perception of the role of EBP for career development and for radiography in general. Conclusion: Radiography students benefit significantly from a training programme in EPB. Such training will hopefully lead to increased research activity among radiographers and a rising awareness that EBP is the foundation for 'best practise'. The cultural shift from 'technician' to 'professional' will require that all professional courses in radiography equip their students with basic knowledge and skills in EBP.
MITIE CT -Innovative education in action D Starkey, T Gunn, C Berry, V Braithwaite, P Bridge, G Mahoney, P Rowntree and K Wilson-Stewart
Queensland University of Technology, Queensland, Australia
Aim: The Medical Imaging Training Immersive Environment (MITIE) system is a recently developed virtual reality (VR) environment for medical imaging that was developed at QUT in 2013. The software platform has recently been expanded to include a virtual reality computed tomography (CT) scanning module. The aim of this project was to evaluate the use of this MITIE software environment in the student learning experience of CT imaging. This project was possible due to funding made available by Health Workforce Australia (HWA). Method: MITIE CT is provided as part of the pedagogical approach for all undergraduate medical imaging (MI) students in their computed tomography imaging unit. As with the other VR MITIE modules, the software presents a realistic imaging environment. The MITIE CT module allows students to position and plan an acquisition for a range of standard CT protocols. The software is utilised in conjunction with a picture archival and communication system (PACS) environment to simulate the processes for CT image acquisition and processing.
Results: This presentation provides a demonstration of the MITIE CT module and the initial feedback from students in its use and contribution to the understanding of the processes for CT imaging. Conclusion: MITIE CT has a role to play in the pre-clinical development of imaging process in CT imaging. Further research is underway to investigate student confidence and clinical skill levels when using MITIE CT as a learning tool. This project was possible due to funding made available by Health Workforce Australia. 
Wales, Australia
Radiotherapy is a complex step-wise process where many hand-offs or transfers of work exist, creating opportunity for error and near situations to occur. Many of these steps and processes can be measured, analyzed with a view to improving patient safety risk. These processes and work systems are relatively simple to control and monitor within an established facility where the various staff groups working together can collaborate closely with one another in person.
Alerting that configuration; adding another facility in a rural / remote setting changes the nature of that ability for people to work closely together. Experience has shown this also makes it harder for all staff to be fully aware of changes and alterations to workflow, work practice and the subtle operations at the various site locations, be those the new site or the established site. Radiation oncology practice relies on staff from many different professions working together towards the same outcome -best practice, safe and effective patient treatment. In a service split by geography, staff and patients need to be supported by a service management framework that measures and analyses operations and workflow system wide, exploring learning opportunities to improve practice and safety. This presentation will provide an overview of systems established with the recent expansion of services at the South Coast Cancer and Hematology Network, following the opening of the new radiation oncology facility at the Shoalhaven Cancer Care Centre. While ongoing this work is centered on a structure that will provide strategic department wide leadership and vision to facilitate ongoing service development and improvement in a network wide coordinated approach.
The revised structure and governance builds on core elements of effective incident monitoring systems, clinical practice audit, national practice standards and multidisciplinary team support.
Leading or managing D Collier

Australian Institute of Radiography, Victoria, Australia
Aim: To explore the differences between leadership and management and the impact of understanding and recognising this can have in the healthcare environment.
Method: This paper explores the shift taking place in our understanding of the role of leadership, from traditional leadership structures based around power and recognition, to those which rely on personal responsibility, delivery and service. These changes mirror similar shifts in healthcare delivery towards the patient-centred focus and multidisciplinary team delivery. 
Conclusion:
We report excellent local control and toxicity with promising survival in both single fraction and multi-fraction SABR treatments for patients with pulmonary metastases screened using FDG-PET scans, with similar outcomes with either approach. Aim: To assess the differences between target volumes delineated using 3D-PET versus 4D-PET for small peripheral lung metastasis planned for SABR. Method: Ten cases of peripheral lung metastasis treated with single fraction SABR were included in the study. Each patient had undergone both 3D-FDG PET/CT and 4D-FDG PET/CT. Contouring and planning were performed using CMS XiO. Three radiation oncologists independently contoured GTVs from 3D-PET/CT and 4D-PET/CT series, applying a 5 mm PTV expansion. Baseline plans were optimised to the 3D-PTV, prescribing to an isodose line between 75% and 85%, using a 3D-PTV coverage objective of D99=100%. DVHs were generated for both 3D and 4D volumes. The absolute volume of GTVs and PTVs was recorded. Target coverage was measured by recording the percentage of PTV covered by the prescription isodose, plus minimum GTV and PTV dose. Plan conformity was quantified by calculating the conformity of the prescription isodose (C.I.100%) and 50% isodose (C.I.50%) to the 3D-PTV. Results: 3D-PTV volumes ranged from 3.98 cc to 52.04 cc. C.I.100% did not vary significantly between cases (mean1.45 +/− SD 0.11); however, C.I.50% was inversely proportional to PTV volume. All cases failed to achieve the D99=100% PTV coverage objective when applying the 3D based plan to the 4D-PTV. The percentage of 4D-PTV covered by the prescription isodose proved variable, ranging from 80.03% to 98.58% (mean 89%). Minimum dose to the 4D-GTV and 4D-PTV was 101.8% and 72.4% respectively, suggesting that the GTV is more protected from motion than the PTV.
Our results demonstrate differences in GTV and PTV dimensions between 3D-FDG and 4D-FDG PET/CT studies. When applying the 3D based plan to the 4D-PTV, all cases failed to meet the PTV coverage objective. Results of this study suggest inadequacy of 3D-PET/CT target delineation when compared to 4D-PET/CT volumes. Access to appropriate treatment for lung cancer patients is a significant problem with impact on survival especially in patients in regional and remote areas of Australia 2 .
Aim: To describe the collaborative implementation of a SABR program across several centres in Australia. Method: A tripartite expert committee consisting of a number of radiation oncologists, radiation therapists and physicists formed a collaboration group with special expertise in implementing SABR. After a series of telephone conferences and setup of an email group, a consensus protocol was developed to enable the implementation and safe delivery of SABR in several centres including regional sites. Results: These protocols had ethics approval and all collaborative sites are required to undergo accreditation of their physics quality assurance, radiotherapy planning and treatment delivery prior to being permitted to treat on collaborative protocols. A clinical trial database and archive were created, to collate all clinical, imaging and radiotherapy planning data. Data collection is supported by a full-time trial coordinator who also assists departments with administration. In total, 11 sites have ethics and 7 have site specific approval to run the study. The setup of an email group has been a useful forum to exchange ideas and share expertise in treatment of patients using SABR. Conclusion: SABR requires expertise from several disciplines and the setup of a collaborative special interest group greatly aids in the successful and safe implementation of such techniques. It provides the necessary support for those centres which do not have SABR specialist staff, allowing them to implement a SABR program safely and to the highest quality.
The role of stereotactic body radiotherapy (SBRT) in the treatment of oligometastatic prostate cancer (PCa) -Initial experiences at Epworth Radiation Oncology (ERO) N Bailey and P Bowden
Epworth Radiation Oncology, Victoria, Australia
Aim: SBRT aims to deliver an ablative dose of radiotherapy to target tissues, minimising dose to adjacent healthy structures. Oligometastasis describes an intermediate disease state involving five or fewer metastases. Local control (LC) rates of 90% for PCa bony and lymph node metastases treated with SBRT are reported in literature 1,2 . This study aims to evaluate the effectiveness of SBRT for PCa oligometastases, assessing improvements in LC, reduction of prostate-specific antigen (PSA) and disease progression. Method: From May 2013 to March 2014, 37 men with 80 PCa lesions were treated with SBRT at ERO. Treatment sites included spine (n = 32), other bony sites (n = 33) and lymph nodes (n = 15). Treatment regimes were 16 Gy in a single fraction, 35 Gy in 5 fractions, or 50 Gy in 10 fractions. All patients had a detectable PSA at the time of radiotherapy. Treatment techniques were intensity modulated radiation therapy for spinal tumours or dynamic conformal arcs for lymph nodes and nonspine bony sites. All sites required strict patient immobilisation. Precise tumour localisation was achieved utilising ExacTrac kV imaging for bony sites, and a combination of ExacTrac kV and Cone Beam CT for nodal sites. All positioning utilised a robotic couch with 6 degrees of freedom.
Results:
Early results indicate SBRT for PCa bone oligometastases is effective for long-term pain relief. No acute toxicity was reported in the majority of cases; <8% had nausea or diarrhoea that required pharmacological management. The first post-SBRT PSA was lower than pre-treatment levels in 88% of patients and continued to decline in greater than 70% of patients at subsequent follow-up. Conclusion: Preliminary results show oligometastatic PCa patients may be safely and successfully treated with SBRT. Further follow-up is necessary to assess the long-term impact of SBRT on LC, toxicity, PSA response, and clinical outcomes.
Are 6MV X-rays all it takes for SABR?
T Kron, D Pham, A Lim, N Hardcastle, A Edgar, P Lonski,
F Foroudi, D Ball and S Siva
Peter MacCallum Cancer Centre, Melbourne, Australia Aim: To explore the role of radiation qualities other than 6MV X-rays in extracranial stereotactic ablative body radiotherapy (SABR) Methods: Peter MacCallum Cancer Centre has an active programme of SABR ranging from lung to spine, bone, liver and kidney lesions. The variety of lesions sizes and locations makes treatment planning challenging and we employ 3D conformal and IMRT techniques for this purpose using mostly 6MV X-rays. 18MV X-rays were investigated as they have the advantage of better penetration and skin sparing but come at the expense of production of unwanted neutrons and a considerably larger uncertainty of dose calculation in the presence of inhomogeneities. We also studied the role of electrons in treating superficial bone lesions. Here typically an electron photon mix would be required to maintain acceptable skin dose and careful consideration must be given to prescription and normalisation of dose.
Results: High energy photons were used mostly for patients with abdominal lesions. In particular for renal lesions, which feature several posterior beams going through couch and immobilisation device (ELEKTA bodyfix), the additional skin sparing afforded by the increased build-up was found to be beneficial. A mix of 6 and 18MV X-rays was employed in more than half of the 20 kidney SABR patients. Skin sparing was verified in selected patients using in vivo dosimetry with radiochromic film. Electrons were used in two patients with bone lesions (sternum and skull). Doses per fraction were 14 and 20 Gy, respectively, with approximately 50% of the dose delivered using a 9 MeV energy electron beam.
Conclusion:
As SABR applications extend to more and more locations, radiation qualities other than the standard 6MV X-rays were found to be useful. They need to be carefully considered on a case by case basis and additional quality assurance may be required. Tables 1 and 2 with data restricted to using "Head" phantom" for brain and "Body" phantom" for all other examinations. The WCH DRL compare well with those of the NDRLD. Separate analysis of axial and helical data shows that DLP values are higher for helical scans due to helical-over-beaming. 
The current database will be analysed on a regular basis to provide ongoing awareness to staff of the doses delivered and review the protocols and procedural techniques. Aim: This presentation will look at the major drivers for change in healthcare and more specifically in diagnostic radiology, and, by reflecting on the recent past, look at how radiology may develop in the next 20 years The recent past has seen a step change in the role of radiology in healthcare. Much of this has been due to the major developments within the specialty itself. However, there are other powerful drivers for change that will have a major influence on the future of radiology. These drivers are outwith health science itself and include the changing population demography, economic challenges and changes in culture. Added to this there are the technological advances that are making the world a smaller place and changing the way we communicate. Although it is not possible to predict the future with accuracy, there is no doubt that radiology will need to adapt to these drivers. The role of the radiologist is under threat, but with all threats come opportunities for developing the specialty into the future. This presentation will explore how these various drivers may influence how we provide diagnostic imaging services in the future.
Radiotherapy services England: Progress and vision for 2024 C Beardmore
The Society and College of Radiographers, London, United Kingdom Overview: In 2004 the government in England set up an ambitious plan to identify the requirements for world class radiotherapy service delivery for patients 1 . This presentation will reflect on the progress made, and focus on the vision for radiotherapy services over the next 10 years 2, 3 .
Background: The population of the United Kingdom is over 63 million. Radiotherapy services are delivered across 61 National Health Service (NHS) Trusts in the UK (51 NHS Trusts in England) and there are a growing number of private providers in England.
The four countries of the UK have devolved health policy and thus the strategy for radiotherapy service development is different by country. However there has and continues to be a strong emphasis on sharing developments between the countries. There have been many challenges and opportunities with a re-organisation of the NHS, in England in 2012 leading to changing for the commissioning of radiotherapy services 3, 4 . Progress is being made due to the commitment of the radiotherapy professionals working with the key stakeholder organisations. Collaboration and engagement has been critical and this co-ordinated approach is helping support the drive to ensure that the radiotherapy strategy continues to support the delivery of world class service to patients 5, 6, 7, 8 .
A new vision for radiotherapy service has been published, and this will be shared during the presentation together with the latest national work to support this vision 7 .
Summary: An overview will be provided of work in progress within England in relation to radiotherapy service delivery: both equipment and workforce 8,9 .
Personalised radiotherapy using risk adaptive optimisation W A Tomé
Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, United States of America
Aim: To review the rationale and physical aspects of biologically guided radiation therapy. Methods: A series of biologically guided radiation therapy techniques are compared to their corresponding plans in which the entire PTV receives a homogenous boost dose resulting in the same equivalent uniform dose (EUD) to it as in the case of dose painting. Iso-TCP maps are introduced as a tool to aid the planner in the evaluation of the resulting non-uniform dose distributions. Iso-TCP maps are akin to isodose maps in 3D conformal radiotherapy. The impact of the currently limited diagnostic accuracy of functional imaging on biologically guided radiation therapy is also explored. Results: Utilizing biological parameters in the generation of biologically guided radiation therapy plans results in an increase in the therapeutic ratio as compared to conventional plans in which optimization techniques based on physical dose for dose painting are used.
Conclusion:
For the assessment of the fidelity of biologically guided radiation therapy plans, voxel-based iso-TCP maps present a promising tool. However, due to the detection threshold for identifying highrisk tumor voxels inherent in all functional-imaging techniques, one should choose for the low-risk PTV the biological parameters or physical dose level such that current minimal prescription peripheral doses are achieved for the entire PTV in the resulting biologically guided radiation therapy plan. With the above caveat biologically guided radiation therapy appears to be a promising approach for individualized patient-and disease-specific radiotherapy.
